Tempus will provide genomic sequencing and analysis for Lurie Cancer Center OncoSET, Northwestern’s precision medicine initiative designed to provide personalized care and customized treatment for cancer patients.Tempus, a health-tech company focused on helping doctors personalize cancer care, and the Robert H. Lurie Comprehensive Cancer Cen...
Tempus is pleased to announce the opening of the Tempus Lab, a highly robotic laboratory optimized for high-throughput clinical next-generation sequencing with a capacity of 52,000 samples annually. “As a scientist, producing high-quality, trustworthy data is critical,” said Sam Bettis, Director of Laboratory Operations at Tempus. “Tempus has invested...
Arul Chinnaiyan, M.D., Ph.D, a renowned leader in the study of cancer genomics, has joined Tempus as a Scientific Adviser. In this role, he will bring his expertise translating groundbreaking genomic research into the clinic. “Arul has spent the last 15 years researching how changes in the...
Dr. Kevin White has joined Tempus as President, where he will oversee the scientific operation. “We are thrilled to have someone of Kevin’s reputation join Tempus, as he is a recognized leader in integrating genomics and systems biology into cancer care,” said Eric Lefkofsky, Co-founder and CEO...